SUTNTIB AB Tewox publishes its NAV for October 2025
Globenewswire· 2025-11-03 21:47
Vilnius, Lithuania, Nov. 03, 2025 (GLOBE NEWSWIRE) -- As at the end of October 2025, the net asset value (NAV) of SUTNTIB AB Tewox decreased to EUR 44,897,707, compared to the previously determined NAV of EUR 45,276,142 at the end of September 2025. The share price decreased to EUR 1.0725, from EUR 1.0815 at the end of September 2025. The pro-forma internal rate of return (IRR) decreased to 3.09%, compared to previously announced IRR of 3.41% at the end of September 2025. Contact person for further informat ...
Worksport ($WKSP) to Showcase SOLIS™ and COR™ at SEMA 2025, Expanding Global Distribution Opportunities
Globenewswire· 2025-11-03 21:45
Company to Meet Dealers, Distributors and Showcase Industry-Defining Clean-Tech Solutions — SOLIS Solar Tonneau and COR Portable Energy System — in SEMA’s “New Product” Evaluation Category West Seneca, New York, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Worksport Ltd. (NASDAQ: WKSP) (“Worksport” or the “Company”), a U.S.-based innovator in advanced manufacturing and distributed clean energy technologies, serving both consumer and industrial markets, today announced that it will be exhibiting at the 2025 SEMA Show i ...
First Commonwealth Financial Corporation Appoints Joseph V. DiVito Jr. to Board of Directors
Globenewswire· 2025-11-03 21:45
INDIANA, Pa., Nov. 03, 2025 (GLOBE NEWSWIRE) -- First Commonwealth Financial Corporation (NYSE: FCF) today announced the appointment of Joseph V. DiVito Jr. to its Board of Directors, effective immediately. DiVito brings a wealth of experience in information technology, cybersecurity, regulatory compliance, data privacy, and governance, having served clients across a broad range of industries during his distinguished career. “We are pleased to welcome Joe to the First Commonwealth Board of Directors,” said ...
Immix Biopharma’s NXC-201 NEXICART-2 Clinical Trial Results Selected for Oral Presentation at ASH 2025
Globenewswire· 2025-11-03 21:45
- Oral presentation Sunday, December 7, at ASH 2025 - LOS ANGELES, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. (“ImmixBio”, “Company”, “We” or “Us” or ”IMMX”), the global leader in relapsed/refractory AL Amyloidosis, today announced that Phase 1/2 interim results from its U.S. NXC-201 NEXICART-2 trial in relapsed/refractory AL Amyloidosis has been selected for oral presentation at the upcoming American Society of Hematology 2025 Annual Meeting (ASH 2025) being held in Orlando, Florida, December ...
Exodus Movement, Inc. to Announce Third Quarter 2025 Results on November 10, 2025
Globenewswire· 2025-11-03 21:45
OMAHA, Neb., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Exodus Movement, Inc. (NYSE American: EXOD) ("Exodus"), a leading self-custodial cryptocurrency platform, today announced that it will provide a business update and release its third quarter financial results on Monday, November 10, 2025, before market open. An earnings conference webcast will be held at 8:30 AM ET on the same day. To access the webcast, please use this link. It will also be available on the Company’s website www.exodus.com. Supplementary mater ...
Latin Metals and Daura Gold Agree to Option Terms for Cerro Bayo and La Flora Projects, Santa Cruz Province, Argentina
Globenewswire· 2025-11-03 21:45
VANCOUVER, British Columbia, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Latin Metals Inc. ("Latin Metals" or the "Company") - (TSXV: LMS) (OTCQB: LMSQF) is pleased to announce that it has entered into a binding Letter Agreement ("Agreement”) with Daura Gold Corp. ("Daura") (TSX.V: DGC) under the terms of which, Daura can earn up to an 80% interest in the Cerro Bayo ("Cerro Bayo") and La Flora projects (together the "Properties"). Option Terms Daura will be granted the option (the "Option") to earn a 75% undivided in ...
VivoPower Enters Heads of Agreement with KOSDAQ Listed KWeather to Launch Initial US$5 Million XRP Focused Digital Asset Reserve & WeatherCoin Tokenization Project in South Korea
Globenewswire· 2025-11-03 21:45
合作核心条款 - VivoPower计划投资500万美元以换取KWeather约20%的股份,并成为其第二大股东[1][1] - VivoPower将获得KWeather董事会5个席位中的2个[1] - 双方签署了不具约束力的协议纲要,目标是在2025年11月30日前达成最终协议[1][4] 战略举措与目标 - 合作目标是使KWeather成为韩国首家也是唯一一家为股东提供XRP及潜在Ripple Labs股份投资敞口的上市公司[1][4] - 双方计划共同推出全球首个WeatherCoin代币,作为一种天气衍生工具,应用于气候风险管理等领域[1] - KWeather的数字资产库策略旨在增加其底层XRP持有量,并系统性地使用融资收益购买VivoPower股票[1] 公司背景与市场地位 - KWeather是韩国最大的天气数据公司,成立于1997年,自2024年起在KOSDAQ上市,在天气行业中占据约90%的市场份额[1][3] - KWeather的核心业务包括天气和空气数据即服务以及空气测量与改善解决方案[3][5] - VivoPower是一家以可持续发展为驱动的企业,正在进行数字资产转型,其新方向侧重于作为多元化数字库策略的一部分,收购、管理和长期持有XRP数字资产[7] - VivoPower业务遍及英国、澳大利亚、北美、欧洲、中东和东南亚,旗下拥有Tembo和Caret Digital两个业务单元[8] 战略意义与领导层观点 - 韩国市场对VivoPower具有重要战略意义,因为韩国国民是全球持有XRP数量和价值最高的群体[4] - KWeather吸引VivoPower的因素包括其数十年积累的丰富的天气和空气数据集[4] - VivoPower新成立的数字资产部门Vivo Federation旨在美国以外地区扩展其数字资产库策略,通过战略性收购上市公司来构建一个符合其去中心化、影响力驱动金融愿景的全球网络[2]
SurgePays to Host Third Quarter 2025 Earnings Conference Call
Globenewswire· 2025-11-03 21:45
BARTLETT, Tenn., Nov. 03, 2025 (GLOBE NEWSWIRE) -- SurgePays, Inc. (NASDAQ: SURG)("SurgePays" or the "Company"), a wireless and fintech technology company connecting underserved consumers to essential mobile and financial services, today announced that it plans to host a conference call and report its financial results for the third quarter ended September 30, 2025, on Wednesday, November 12, 2025. Event: SurgePays Third Quarter 2025 Financial Results Conference CallDate: Wednesday, November 12, 2025Time: 5 ...
AITX’s RAD Wins New Fortune 500 Manufacturer, Displacing Established Competitor
Globenewswire· 2025-11-03 21:40
Initial RIO Deployments in the U.S. and Canada Mark the Start of a Larger Opportunity with the Multinational Industrial Brand Detroit, Michigan, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Artificial Intelligence Technology Solutions, Inc. (the “Company”) (OTCID:AITX), a global leader in AI-driven security and productivity solutions, along with its wholly owned subsidiary, Robotic Assistance Devices, Inc. (RAD), has received initial orders from a Fortune 500 manufacturer and multinational industrial brand. The client ...
Outlook Therapeutics Re-Submits Biologics License Application for ONS-5010
Globenewswire· 2025-11-03 21:35
ISELIN, N.J., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on optimizing the standard of care for bevacizumab for the treatment of retina diseases, today announced it has re-submitted its Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for ONS-5010, after receiving the official minutes from the FDA Type A meeting conducted in September 2025. ONS-5010 is an investigational ophthalmic formulation of bevacizu ...